Cannalysis Overview

  • Founded
  • 2015
  • Status
  • Private
  • Employees
  • 38
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $22.6M
Latest Deal Amount
  • Investors
  • 1

Cannalysis General Information


Operator of a clinical laboratory intended to offer testing facilities for medical and recreational cannabis products. The company's services include medical and chemical residue tests in order to check the presence of industrial solvents, pesticides and unwanted microbes like E. coli or yeast, enabling the healthcare industry to receive chemical and pesticide-free cannabis meant for clinical and recreational use.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Laboratory Services (Healthcare)
Primary Office
  • 1801 Carnegie Avenue
  • Suite 124
  • Santa Ana, CA 92705
  • United States
+1 (949) 000-0000

Cannalysis Timeline

Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Cannalysis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series A) 18-Sep-2019 $22.6M 000.00 Completed Generating Revenue
2. Secondary Transaction - Private 01-Jan-2019 000 Completed Generating Revenue
1. Seed Round 09-Nov-2017 $1M $1M 000 Completed Generating Revenue
To view Cannalysis’s complete valuation and funding history, request access »

Cannalysis Cap Table

Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 0,000,000 00 00.0 00.0 00 00.0 00.000
To view Cannalysis’s complete cap table history, request access »

Cannalysis Comparisons

HQ Location
Total Raised
Post Valuation
Last Financing Details
Operator of a clinical laboratory intended to offer testing facilities for medical and recreational cannabis products. T
Laboratory Services (Healthcare)
Santa Ana, CA
38 As of 2020
00000000000 000.00


a. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo
0000000000 00000000 (0000000000)
Acton, MA
000 As of 0000
000000000 -

00000 00

laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate
0000000000 00000000 (0000000000)
Berkeley, CA
00 As of 0000
0000000000 0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Cannalysis Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Psychemedics Corporation Acton, MA 000 000000000 -
00000 0000 Venture Capital-Backed Berkeley, CA 00 000.00 0000000000 0 000.00
0000000 Formerly VC-backed Vancouver, Canada 00 000.00 000000&0 000.00
To view Cannalysis’s complete competitors history, request access »

Cannalysis Executive Team (4)

Name Title Board Seat Contact Info
Tyler Autera Co-Founder and Chief Operating Officer
Tom Autera Chief Technology Officer
To view Cannalysis’s complete executive team members history, request access »

Cannalysis Board Members (1)

Name Representing Role Since
Chris Hetherington Self Board Member 000 0000
To view Cannalysis’s complete board members history, request access »

Cannalysis Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cannalysis Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
CanLab Corporation Minority 000 0000 000000 0
To view Cannalysis’s complete investors history, request access »